Stock·NASDAQ·Consumer Cyclical
Papa John's International, Inc. (PZZA)
- Market cap
- $638.35M
- P/E
- 24.46
- Dividend yield
- 9.49%
- Street target
- $27.50median of 13 analysts
- 52-week range
- $18.78 $55.74
The short version
Where PZZA stands today, in four lines, and what CleaRank Financial AI makes of it.
PZZA at a glance
Papa John's International, Inc. (PZZA): Sell, 35/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($21.58 and $31.05).
- Earnings PZZA beat estimates in 5 of its last 6 quarters, yet fell the next day after 4 of those beats.
- Valuation P/E of 24.5 against 20.8 for the Consumer Cyclical sector: broadly in line with peers (+18%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Papa John's International, Inc. (PZZA) Sell, with a model score of 35/100.
The earnings record lifts the score most: it beat estimates in 5 of its last 6 reports and the latest report beat the estimate by 2.22%. The trend holds it back most: the price is 37.54% below its 200-day average and 10.14% below its 50-day average, and the 50-day average is 30.49% below the 200-day. The 50-day average stands at $21.58 and the 200-day at $31.05. Over the past year the price fell 63.44%.
Only on CleaRank
Figures we compute ourselves from PZZA's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $19.39 is 10.1% below the 50-day simple moving average of $21.58.Price above its 200-day average ›
The price is 37.5% below the 200-day simple moving average of $31.05.50-day average above the 200-day ›
The 50-day average ($21.58) is 30.5% below the 200-day average ($31.05), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 2% of its 52-week range, between $18.78 and $55.74.
PZZA share price
Pick a period: each tab shows how far PZZA has moved over it, to the last close.
Today's trading
Where PZZA sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 24.46 is 17.6% above the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 0.33 is 82.8% below the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $26.3M on revenue of $2.0B, a net margin of 1.3%.Beat estimates in most recent reports ›
PZZA beat the EPS estimate in 5 of its last 6 reports.Pays a dividend ›
The trailing dividend yield is 9.49%, or $1.84 a share a year.
Key statistics
The headline figures for PZZA.
As of October 17, 2026, PZZA trades at $19.39, with a market value of $638.35M, a P/E ratio of 24.46 and a dividend yield of 9.49%.
What the numbers say
CleaRank Financial AI's reading of PZZA's valuation, growth and risks.
PZZA trades at 24.46 times trailing earnings, which puts its P/E 17.6% above the Consumer Cyclical median of 20.8. The peer comparison on this page calls that P/E broadly in line with peers. On sales, the P/S of 0.33 is 82.6% below the sector median of 1.9. To put the size in context, the company's market value is $638.4M.
Revenue fell 8.80% over the latest year, which is 16.0 percentage points behind the 7.2% median for Consumer Cyclical. Profitability shows a net margin of 1.40% and an operating margin of 5.74%. It generates a return on equity of -6.83%, below the sector median of 12.4%. It also reports a trailing dividend yield of 9.49% ($1.84 a share a year).
PZZA reported EPS of $0.46 in its most recent quarterly report, released on August 6, 2026. Analysts had expected $0.45, so the company beat the estimate by 2.22%. Despite the beat, the share price dropped 0.69% in the first session after the report.
Over its last 6 reports, PZZA topped the estimate 5 times, but beats have not guaranteed gains: the stock fell the next day after 4 of them. Earlier, the stock fell 4.06% after the November 6, 2025 report, a miss of 21.95%. The consensus EPS estimate stands at $1.18 for this fiscal year and $1.33 for next, a decline of 17.3% for the current year.
PZZA's daily returns have a 30-day standard deviation of 2.34%. For as long as the price stays under both moving averages, the downtrend remains a risk in its own right. The stock is also 65.21% below its 52-week high of $55.74.
PZZA against the Consumer Cyclical sector
How PZZA compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (18% difference), suggesting fair market pricing relative to industry standards.
Return vs SPY: Since May 6, 2025, PZZA has lost 42.7% against a gain of 36.6% for SPY.
Performance against SPY
PZZA and the Consumer Cyclical sector fund over the same days.
Revenue and earnings
How much PZZA sells, and how much of it becomes profit.
Revenue growth: Revenue fell 0.3% in FY2025 to $2.1B, from $2.1B a year earlier.
Profit margin: The net margin was 1.6% in FY2025, down from 4.1% the year before.
Profitable: PZZA earned $32.1M in FY2025.
Earnings reality check
Did PZZA beat what analysts expected, and how did the stock react?
Earnings record: PZZA beat the analyst estimate in 5 of the last 6 quarters.
Market reaction: The stock fell in the first session after 4 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 6, 2026after close | $0.45 | $0.46 | +2.22% | -0.69% | -0.85% |
| Feb 26, 2026after close | $0.33 | $0.34 | +3.03% | +1.42% | +0.32% |
| Nov 6, 2025after close | $0.41 | $0.32 | -21.95% | -4.06% | -4.93% |
| Aug 7, 2025after close | $0.34 | $0.41 | +20.59% | -1.55% | +8.18% |
| May 8, 2025after close | $0.35 | $0.36 | +2.86% | -0.85% | +3.76% |
| Feb 27, 2025after close | $0.50 | $0.63 | +26.00% | -3.28% | -0.79% |
As of October 17, 2026, PZZA has beaten the analyst EPS estimate in 5 of its last 6 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on August 6, 2026, came in 2.22% above the estimate and the stock moved -0.69% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 37.2, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 37.2 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of PZZA
The score, the reasoning behind it, and what could move the price next.
PZZA is trading at $19.39, below both of its main moving averages. The stock sits 10.14% below its 50-day average of $21.58 and 37.54% below its 200-day average of $31.05. Its price is at 2% of the 52-week range, which leaves it 3.25% above the 52-week low of $18.78. The 50-day average is 30.49% below the 200-day, and that gap backs up the weakness instead of disputing it.
On momentum, the 14-day RSI reads 37.2, in the bearish zone, above the oversold line, with the MACD line negative. Every period on the chart shows a loss, with the price down 40.99% over the past three months, 48.24% over the past six months and 63.44% over the past year.
Earnings beat ›
The August 6, 2026 report beat the EPS estimate by 2.22%, and the share price fell 0.69% in the first session after it.
Source: Earnings report, August 6, 2026
Analyst downgrade ›
Benchmark downgraded it to Hold from Buy on August 7, 2026.
Source: Analyst action, Benchmark, August 7, 2026Analyst downgrade ›
Stephens & Co. downgraded it to Equal-Weight from Overweight on August 7, 2026.
Source: Analyst action, Stephens & Co., August 7, 2026
- Two levels deserve the most attention: the 20-day EMA at $19.94, which sits above the price, and the 52-week low at $18.78, which sits below it.
- The 14-day RSI stands at 37.2, which is in the bearish zone, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- In the first session after the August 6, 2026 report, the share price slipped 0.69%. Over the last 6 reports, PZZA beat estimates 5 times.
PZZA remains in a downtrend while it sits below both its 50-day average of $21.58 and its 200-day average of $31.05. A close back above the 50-day average would be the first sign of repair. Overhead, the 20-day EMA at $19.94 is the first level the price would have to clear.
The next level below the price is the 52-week low of $18.78. With the RSI in the bearish band, momentum argues against a fast rebound.
Technical indicators
Momentum and trend for PZZA, from its daily closes.
As of October 17, 2026, with PZZA at $19.39, its 14-day RSI is 37.2 (showing bearish momentum without being oversold), its 50-day simple moving average is $21.58 and its 200-day is $31.05.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What PZZA moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, PZZA's 1-year correlation of daily returns is +0.21 with S&P 500 (SPY), +0.16 with Nasdaq 100 (QQQ), +0.06 with Bitcoin (BTC) and +0.04 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
2 of 13 analysts rate it a buy or strong buy, 10 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $27.50 is 41.8% above the price.More buy ratings than three months ago ›
2 of 13 rate it a buy now, against 4 of 14 three months ago.
PZZA Wall Street View
12-month price targets
The price, $19.39, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 7, 2026 | UBS | Maintains | Neutral |
| Aug 7, 2026 | Benchmark | Downgrade | Hold |
| Aug 7, 2026 | Piper Sandler | Maintains | Neutral |
| Aug 7, 2026 | Stephens & Co. | Downgrade | Equal-Weight |
| Jul 31, 2026 | Mizuho | Maintains | Neutral |
| Jul 13, 2026 | B of A Securities | Downgrade | Underperform |
As of October 17, 2026, 13 Wall Street analysts cover PZZA: 2 rate it a buy or strong buy, 10 a hold and 1 a sell or strong sell. Their 12-month price targets range from $24.00 to $43.00, with a median of $27.50, 41.8% above the price of $19.39.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
PZZA trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from PZZA's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much PZZA tends to move, against the market and on its own.
The long record
PZZA's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 2.34% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 83.4%, from December 2021 to October 2026; the price is still 83.3% below that peak.Most 1-year holds ended higher ›
37% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $3,130.28, against $42,055 in the S&P 500 (SPY).
PZZA Drawdowns & Recovery
As of October 17, 2026, PZZA's worst peak-to-trough fall over the last 10 years with dividends reinvested was -83.4% (December 2021 to October 2026); it is still 83.3% below that peak, and 37% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into PZZA in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: PZZA trailed the S&P 500 over this period: $3,130.28 against $42,055.
A $10,000 investment in PZZA in October 2016 would be worth about $3,130 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to PZZA, and which have not.
Strongest month, April: an average of +3.26%, up in 5 of 10 years.
Weakest month, March: an average of -4.43%, up in 1 of 10 years.
This month, October: has averaged -0.09%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, PZZA's strongest calendar month has been April (average +3.26%, up in 5 of 10 years) and its weakest March (average -4.43%, up in 1 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in PZZA, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in PZZA today could grow to about $6,417 by 2036 in the base case, with a 90th-percentile outcome near $35,459 and a 10th-percentile outcome around $1,161. The simulation models price only; at today's 9.49% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
PZZA Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $16.24 for PZZA by 2030 in the base case, from $19.39 today (0.8x over 4 years). The 10th-percentile path ends near $5.51. These are outcomes of a Monte Carlo simulation run on PZZA's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $10.80 | $18.55 | $31.85 | |
| 2028 | $8.26 | $17.74 | $38.11 | |
| 2029 | $6.66 | $16.97 | $43.29 | |
| 2030 | $5.51 | $16.24 | $47.87 | |
| 2031 | $4.64 | $15.53 | $52.02 |
Method: a lognormal simulation of PZZA's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
PZZA insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Insider buying: No insider bought PZZA shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 29, 2026 | Christopher L Coleman
Director
|
Grant | 378 | $12.9K |
| May 29, 2026 | John W Garratt
Director
|
Grant | 156 | $5.3K |
| May 29, 2026 | Stephen L Gibbs
Director
|
Grant | 156 | $5.3K |
| May 29, 2026 | Laurette T Koellner
Director
|
Grant | 328 | $11.2K |
| May 29, 2026 | Jocelyn C Mangan
Director
|
Grant | 271 | $9.3K |
| May 29, 2026 | Sonya E. Medina
Director
|
Grant | 274 | $9.4K |
| May 29, 2026 | John Chris Miller
Director
|
Grant | 159 | $5.4K |
| May 11, 2026 | Christopher L Coleman
Director
|
Grant | 7.0K | - |
| May 11, 2026 | John W Garratt
Director
|
Grant | 4.5K | - |
| May 11, 2026 | Stephen L Gibbs
Director
|
Grant | 4.5K | - |
| May 11, 2026 | Laurette T Koellner
Director
|
Grant | 4.5K | - |
| May 11, 2026 | Jocelyn C Mangan
Director
|
Grant | 4.5K | - |
| May 11, 2026 | Sonya E. Medina
Director
|
Grant | 4.5K | - |
| May 11, 2026 | John Chris Miller
Director
|
Grant | 4.5K | - |
| Mar 2, 2026 | Christopher K Collins
Officer
|
Grant | 11.2K | - |
| Mar 2, 2026 | Caroline Miller Oyler
Officer
|
Grant | 19.6K | - |
| Mar 2, 2026 | Todd Allan Penegor
Chief Executive Officer
|
Grant | 100.2K | - |
| Mar 2, 2026 | Ravi Thanawala
Officer
|
Grant | 39.1K | - |
| Mar 2, 2026 | John Kevin Vasconi
Chief Technology Officer
|
Grant | 19.6K | - |
| Feb 20, 2026 | Christopher L Coleman
Director
|
Grant | 304 | $9.6K |
| Feb 20, 2026 | John W Garratt
Director
|
Grant | 103 | $3.3K |
| Feb 20, 2026 | Stephen L Gibbs
Director
|
Grant | 103 | $3.3K |
| Feb 20, 2026 | Laurette T Koellner
Director
|
Grant | 288 | $9.1K |
| Feb 20, 2026 | Jocelyn C Mangan
Director
|
Grant | 226 | $7.1K |
| Feb 20, 2026 | Sonya E. Medina
Director
|
Grant | 230 | $7.3K |
| Feb 20, 2026 | John Chris Miller
Director
|
Grant | 106 | $3.3K |
| Nov 28, 2025 | Christopher L Coleman
Director
|
Grant | 223 | $9.4K |
| Nov 28, 2025 | John W Garratt
Director
|
Grant | 75 | $3.2K |
| Nov 28, 2025 | Stephen L Gibbs
Director
|
Grant | 75 | $3.2K |
| Nov 28, 2025 | Laurette T Koellner
Director
|
Grant | 212 | $8.9K |
| Nov 28, 2025 | Jocelyn C Mangan
Director
|
Grant | 166 | $7.0K |
| Nov 28, 2025 | Sonya E. Medina
Director
|
Grant | 169 | $7.1K |
| Nov 28, 2025 | John Chris Miller
Director
|
Grant | 78 | $3.3K |
| Aug 29, 2025 | Christopher L Coleman
Director
|
Grant | 192 | $9.4K |
| Aug 29, 2025 | John W Garratt
Director
|
Grant | 65 | $3.2K |
| Aug 29, 2025 | Stephen L Gibbs
Director
|
Grant | 65 | $3.2K |
| Aug 29, 2025 | Laurette T Koellner
Director
|
Grant | 182 | $8.9K |
| Aug 29, 2025 | Jocelyn C Mangan
Director
|
Grant | 143 | $7.0K |
| Aug 29, 2025 | Sonya E. Medina
Director
|
Grant | 145 | $7.1K |
| Aug 29, 2025 | John Chris Miller
Director
|
Grant | 67 | $3.3K |
| Jun 5, 2025 | Caroline Miller Oyler
Officer
|
Grant | 2.4K | - |
| May 30, 2025 | Christopher L Coleman
Director
|
Grant | 205 | $9.3K |
| May 30, 2025 | John W Garratt
Director
|
Grant | 69 | $3.1K |
| May 30, 2025 | Stephen L Gibbs
Director
|
Grant | 69 | $3.1K |
| May 30, 2025 | Jocelyn C Mangan
Director
|
Grant | 153 | $6.9K |
| May 30, 2025 | Sonya E. Medina
Director
|
Grant | 155 | $7.0K |
| May 30, 2025 | John Chris Miller
Director
|
Grant | 72 | $3.3K |
| May 12, 2025 | Christopher L Coleman
Director
|
Grant | 5.4K | - |
| May 12, 2025 | John W Garratt
Director
|
Grant | 3.3K | - |
| May 12, 2025 | Stephen L Gibbs
Director
|
Grant | 3.3K | - |
| May 12, 2025 | Laurette T Koellner
Director
|
Grant | 3.3K | - |
| May 12, 2025 | Jocelyn C Mangan
Director
|
Grant | 3.3K | - |
| May 12, 2025 | Sonya E. Medina
Director
|
Grant | 3.3K | - |
| May 12, 2025 | John Chris Miller
Director
|
Grant | 3.3K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.